Ramprasad Reddy has his skin the game; he has made some timely bets with a nifty strategy for Aurobindo.

Mylan Laboratories agreed to buy Merck KGaA’s generic-drug unit for 4.9 billion euros ($6.7 billion) in cash to become the world’s third-la...